We investigated the performance of blood and chocolate agar as alternatives to Middlebrook 7H11 agar for testing the susceptibility of Mycobacterium tuberculosis to first-and second-line drugs by the Etest method. A total of 39 strains of M. tuberculosis including 22 multidrug-resistant M. tuberculosis strains and 17 susceptible strains were tested. In conclusion, our results showed that chocolate agar gave insufficient growth, needing up to 21 days of incubation, while results on blood agar were comparable to those on Middlebrook 7H11 agar and can be further explored as an alternative for Etest-based susceptibility testing of M. tuberculosis.
In this study, the performance of blood and chocolate agar was compared to that of Middlebrook 7H11 agar with the aim to evaluate them as possible alternatives for susceptibility testing of M. tuberculosis clinical isolates against IZ, RI, SM, EB, ofloxacin (OF), ciprofloxacin (CI), levofloxacin (LE), linezolid (LZ), and ethionamide (ET) by Etest.
A total of 39 strains of M. tuberculosis and H37Rv (control strain susceptible to all antituberculous drugs) were tested. While 22 MDR M. tuberculosis strains were isolated from sputum of chronic pulmonary tuberculosis patients in Istanbul, Turkey, 17 susceptible strains were isolated from sputum of pulmonary tuberculosis patients in Samsun, Turkey. All isolates were isolated using the BACTEC 460 TB system and Löwenstein-Jensen medium. Thirty of these 39 strains were also tested with all drugs, including IZ, RI, SM, EB, LZ, OF, CI, LE, and ET, whereas 9 of 39 strains were tested only with IZ, RI, SM, and EB.
Etest strips for nine drugs (IZ, RI, SM, EB, OF, CI, LE, LZ, and ET) were obtained from AB Biodisk, Solna, Sweden. Standard blood (supplemented with 5% sheep blood) and chocolate agar (chocolate agar plus PolyViteX) plates were purchased from Biomerieux, France, and stored at ϩ4°C until use.
The Etest procedure was performed as described by AB Biodisk (1). The agar plates were sealed with a shrink seal and incubated at 37°C in 7 to 10% CO 2 for 5 to 10 days. The plates were visually examined and read after 5 and 10 days of incubation when the mycobacterial lawn of growth and inhibition ellipse became clearly visible ( Fig. 1A and B) .
All MIC results were interpreted into categories (susceptible or resistant) using the CLSI agar proportion breakpoints (22) for intermethod comparisons. Resistance was defined as a MIC of Ͼ0.2 g/ml for IZ, Ͼ1 g/ml for RI, Ͼ7.5 g/ml for EB, Ͼ2 g/ml for SM, Ͼ2 g/ml for OF, Ͼ10 g/ml for ET (22) , Ͼ2 g/ml for CI and LZ, and Ͼ1 g/ml for LE (23, 28) . Agreement of the Etest results for the nine antibiotics on blood agar and chocolate agar compared to the recommended Middle-brook 7H11 agar and BACTEC 460 TB system are summarized in Tables 1, 2 , and 3. All Etest plates were examined after the 10th, 14th, and 21st days of incubation, and Etest results (for all resistant or susceptible strains) were seen on the 10th day on Middlebrook 7H11 agar and blood agar, whereas results on chocolate agar were first obtained on the 21st day of incubation. When the incubation time was extended to 21 days on 7H11 and blood agar, MICs were not changed.
It has been reported recently that M. tuberculosis can be easily grown on blood agar and chocolate agar (10, 11) . Moreover, other studies (6) (7) (8) 31) have noted that blood agar may be suitable for susceptibility testing of M. tuberculosis. We therefore evaluated the use of Etest for testing the susceptibility of M. tuberculosis to IZ, RI, SM, EB, OF, CL, LE, LZ, and ET using three different media: Middlebrook 7H11 agar (recommended by the manufacturer) and blood agar and chocolate agar. Etest has been evaluated for susceptibility testing of M. tuberculosis, especially for the first-line drugs. Wanger and Mills (29, 30) demonstrated an excellent correlation between Etest and agar dilution for M. tuberculosis tested with RI (1994) and suggested that the Etest may be considered as an alternative method for the first-line drugs (1996). Sanchez et al. (25) (15) compared Etest to the standard proportion method using L-J medium in testing IZ, RI, and SM with M. tuberculosis. Although they achieved very good agreements between the methods (97% for RI, 96% for IZ, and 80% for SM), they reported the Etest to be less useful for developing countries because of the expense associated with media, Etest strips, and the need for a CO 2 incubator. Esteban et al. (12) did not recommend the use of Etest for detecting IZ resistance in M. tuberculosis complex strains due to the cost of Etest and the risk of contamination when streaking an agar plate with a high inoculum of viable cells. The manual MGIT and Etest were compared to the proportion method by Fegou et al. (14) , and they concluded that the proportion method remains the method of choice. Delas et al. (9) found that the Etest provided low specificity for detection of resistance to SM and EB and suggested further investigations. In the M. tuberculosis study of Hausdorfer et al. (17) , the Etest was not recommended by the authors for practical use in clinical laboratories due to false susceptibility results.
We investigated the performance of the Etest on three media for both first-and second-line drugs since only a few studies have reported Etest results for second-line drugs for M. tuberculosis. Alcala et al. (3) tested 117 isolates of M. tuberculosis with LZ using the proportion method and Etest and found high LZ in vitro activity against all isolates. We also found all M. tuberculosis clinical isolates to be susceptible to LZ by all methods. Muralidhar and Srivastava (21) tested CI by Etest and the proportion method using both LJ and Middlebrook 7H11 agar. Five isolates were found resistant to CI on the LJ medium, and no resistance was found by the Etest and proportion method on Middlebrook 7H11 agar. In the study by Joloba et al. (19) , results for CI could not be read because of irregular growth along the Etest strip; however, the same investigators found an excellent categorical agreement of 100% for OF between the Etest and the proportion method for both media. In our study, all isolates were susceptible to CI by the Etest on Middlebrook 7H11 agar, while one strain was resistant on blood and chocolate agar. For OF, the agreement was 90% on blood agar and 86.6% on chocolate agar. In this study, the results with blood agar and 7H11 agar for Etest are concordant for time and result (susceptible or resistant). In the other study (8) , the results were concordant, but in one center the results were obtained on the 14th day of incubation for 100 isolates, whereas in the other center, results were obtained on the 21st day of incubation for 47 isolates.
In our country, Middlebrook 7H11 agar is generally used for antituberculous susceptibility testing and research and it requires the OADC supplement. However, blood agar is routinely used. However, Drancourt et al. (11) reported that blood agar saves time, is cost-effective, and is at least as rapid as the automated systems.
In conclusion, Etest results on Middlebrook 7H11 agar and blood agar were equivalent and results could be obtained in 10 days. However, results on chocolate agar were available only after 21 days because of insufficient growth support. For laboratories with no access to Middlebrook 7H11 agar, we recommend blood agar as an alternative medium for the testing of M. tuberculosis susceptibility by Etest and encourage further studies and evaluation of improved versions of blood agar to attempt to shorten the incubation time.
